Identifying Patients With Severe Sepsis Using Administrative Claims Patient-Level Validation of the Angus Implementation of the International Consensus Conference Definition of Severe Sepsis

被引:290
作者
Iwashyna, Theodore J. [1 ,2 ]
Odden, Andrew [1 ]
Rohde, Jeffrey [1 ]
Bonham, Catherine [1 ]
Kuhn, Latoya [2 ]
Malani, Preeti [1 ,3 ]
Chen, Lena [1 ,2 ]
Flanders, Scott [1 ]
机构
[1] Univ Michigan, Dept Med, Ann Arbor, MI 48109 USA
[2] VA Ctr Clin Management Res, Ann Arbor, MI USA
[3] VA Geriatr Res Educ & Clin Ctr, Ann Arbor, MI USA
基金
美国国家卫生研究院;
关键词
severe sepsis; infection; administrative claims; Medicare; sensitivity; positive predictive value; CLINICAL COMORBIDITY INDEX; UNITED-STATES; EPIDEMIOLOGY; MORTALITY; CARE; DEFINITIONS; THERAPIES; SURVIVORS;
D O I
10.1097/MLR.0b013e318268ac86
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
100404 [儿少卫生与妇幼保健学];
摘要
Background:Severe sepsis is a common and costly problem. Although consistently defined clinically by consensus conference since 1991, there have been several different implementations of the severe sepsis definition using ICD-9-CM codes for research. We conducted a single center, patient-level validation of 1 common implementation of the severe sepsis definition, the so-called Angus implementation.Methods:Administrative claims for all hospitalizations for patients initially admitted to general medical services from an academic medical center in 2009-2010 were reviewed. On the basis of ICD-9-CM codes, hospitalizations were sampled for review by 3 internal medicine-trained hospitalists. Chart reviews were conducted with a structured instrument, and the gold standard was the hospitalists' summary clinical judgment on whether the patient had severe sepsis.Results:Three thousand one hundred forty-six (13.5%) hospitalizations met ICD-9-CM criteria for severe sepsis by the Angus implementation (Angus-positive) and 20,142 (86.5%) were Angus-negative. Chart reviews were performed for 92 randomly selected Angus-positive and 19 randomly-selected Angus-negative hospitalizations. Reviewers had a of 0.70. The Angus implementation's positive predictive value was 70.7% [95% confidence interval (CI): 51.2%, 90.5%]. The negative predictive value was 91.5% (95% CI: 79.0%, 100%). The sensitivity was 50.4% (95% CI: 14.8%, 85.7%). Specificity was 96.3% (95% CI: 92.4%, 100%). Two alternative ICD-9-CM implementations had high positive predictive values but sensitivities of <20%.Conclusions:The Angus implementation of the international consensus conference definition of severe sepsis offers a reasonable but imperfect approach to identifying patients with severe sepsis when compared with a gold standard of structured review of the medical chart by trained hospitalists.
引用
收藏
页码:E39 / E43
页数:5
相关论文
共 37 条
[1]
American Medical Association, 2009, ICD 9 CM OFF I C 1 B
[2]
Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care [J].
Angus, DC ;
Linde-Zwirble, WT ;
Lidicker, J ;
Clermont, G ;
Carcillo, J ;
Pinsky, MR .
CRITICAL CARE MEDICINE, 2001, 29 (07) :1303-1310
[3]
The Search for Effective Therapy for Sepsis Back to the Drawing Board? [J].
Angus, Derek C. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 306 (23) :2614-2615
[4]
Management of Sepsis A 47-Year-Old Woman With an Indwelling Intravenous Catheter and Sepsis [J].
Angus, Derek C. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (14) :1469-1477
[5]
The Lingering Consequences of Sepsis A Hidden Public Health Disaster? [J].
Angus, Derek C. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 304 (16) :1833-1834
[6]
Septic shock [J].
Annane, D ;
Bellissant, E ;
Cavaillon, JM .
LANCET, 2005, 365 (9453) :63-78
[7]
[Anonymous], 2009, Modern epidemiology
[8]
Racial variation in the incidence, care, and outcomes of severe sepsis - Analysis of population, patient, and hospital characteristics [J].
Barnato, Amber E. ;
Alexander, Sherri L. ;
Linde-Zwirble, Walter T. ;
Angus, Derek C. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2008, 177 (03) :279-284
[9]
Efficacy and safety of recombinant human activated protein C for severe sepsis. [J].
Bernard, GR ;
Vincent, JL ;
Laterre, P ;
LaRosa, SP ;
Dhainaut, JF ;
Lopez-Rodriguez, A ;
Steingrub, JS ;
Garber, GE ;
Helterbrand, JD ;
Ely, EW ;
Fisher, CJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) :699-709
[10]
DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ .
CHEST, 1992, 101 (06) :1644-1655